U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H12ClN5O3
Molecular Weight 285.687
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLADRIBINE

SMILES

NC1=NC(Cl)=NC2=C1N=CN2[C@H]3C[C@H](O)[C@@H](CO)O3

InChI

InChIKey=PTOAARAWEBMLNO-KVQBGUIXSA-N
InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1

HIDE SMILES / InChI
Molecular Formula C10H12ClN5O3
Molecular Weight 285.687
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:01:30 UTC 2023
Edited
by admin
on Fri Dec 15 15:01:30 UTC 2023
Record UNII
47M74X9YT5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLADRIBINE
EMA EPAR   EP   HSDB   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN   INN  
Official Name English
CLADRIBINE [HSDB]
Common Name English
CLADRIBINE [EP MONOGRAPH]
Common Name English
MAVENCLAD
Common Name English
2-CHLORODEOXYADENOSINE
Systematic Name English
2-CDA
Common Name English
CLADRIBINE [USP MONOGRAPH]
Common Name English
CLADRIBINE [USP-RS]
Common Name English
LITAK
Brand Name English
cladribine [INN]
Common Name English
CLADRIBINE [MART.]
Common Name English
Cladribine [WHO-DD]
Common Name English
ADENOSINE, 2-CHLORO-2'-DEOXY-
Systematic Name English
2-CHLORO-2'-DEOXYADENOSINE
Systematic Name English
CLADRIBINE [ORANGE BOOK]
Common Name English
NSC-105014
Code English
CLADRIBINE [EMA EPAR]
Common Name English
LEUSTATIN
Brand Name English
CLADRIBINE [MI]
Common Name English
CLADRIBINE [VANDF]
Common Name English
CLADRIBINE [JAN]
Common Name English
RWJ-26251
Code English
CLADRIBINE [USP IMPURITY]
Common Name English
CLADRIBINE [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2157
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 54190
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 51690
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
WHO-VATC QL01BB04
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
EU-Orphan Drug EU/3/01/055
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 943223
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
EMA ASSESSMENT REPORTS LITAK (AUTHORIZED: LEUKEMIA, HAIRY CELL)
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 467214
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
LIVERTOX NBK548555
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 68092
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
NCI_THESAURUS C1556
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 77793
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
WHO-ATC L04AA40
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
NCI_THESAURUS C798
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
FDA ORPHAN DRUG 47990
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
NDF-RT N0000175712
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
WHO-ATC L01BB04
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
Code System Code Type Description
DRUG CENTRAL
667
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
LACTMED
Cladribine
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
DAILYMED
47M74X9YT5
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
ChEMBL
CHEMBL1619
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
CHEBI
567361
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
WIKIPEDIA
CLADRIBINE
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
FDA UNII
47M74X9YT5
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
MESH
D017338
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
RXCUI
44157
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY RxNorm
DRUG BANK
DB00242
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
SMS_ID
100000085410
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
CAS
4291-63-8
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
EPA CompTox
DTXSID8022828
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
USAN
DD-79
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
EVMPD
SUB06635MIG
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
PUBCHEM
20279
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
IUPHAR
4799
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
RS_ITEM_NUM
1134200
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
NSC
105014
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
MERCK INDEX
m3606
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY Merck Index
INN
6997
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
NCI_THESAURUS
C1336
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
HSDB
7564
Created by admin on Fri Dec 15 15:01:30 UTC 2023 , Edited by admin on Fri Dec 15 15:01:30 UTC 2023
PRIMARY
Related Record Type Details
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE SUBUNIT
TARGET -> INHIBITOR
RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SUBUNIT M2 B
TARGET -> INHIBITOR
RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE SUBUNIT M2
TARGET -> INHIBITOR
Related Record Type Details
Structure of 2-METHOXY-2'-DEOXYADENOSINE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 2-CHLOROADENINE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 1'-EPI-CLADRIBINE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-DEOXYRIBOSE, D-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (TLC)
EP
Structure of 2-AMINO-2'-DEOXYADENOSINE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of P-TOLUAMIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of METHYL 4-METHYLBENZOATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2'-DEOXYADENOSINE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
Structure of CLADRIBINE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966